Search Within

Department of Medicine

Formats
  1. Journal Article (19594)
  2. Meeting Abstract (16041)
  3. Review (1152)
  4. Book Section (934)
  5. Editorial (610)
  6. Research Letter (314)
  7. Conference Paper (301)
  8. Guidelines (295)
  9. Correspondence (236)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22323)
  2. Hematologic Malignancies, Division of (13278)
  3. Center for Hematologic Malignancies (11061)
  4. GSK Faculty (10647)
  5. Survivorship Research (9333)
  6. Division of Subspecialty Medicine (7539)

More Groups

People
  1. Robert Motzer (1248)
  2. Howard Scher (1132)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (905)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1077)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4216)
  3. American Society of Hematology (4003)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2287)
  6. Nature Publishing Group (2111)

More Publishers

Results (39628)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A dedicated structured data set for reporting of invasive carcinoma of the breast in the setting of neoadjuvant therapy: Recommendations from the International Collaboration on Cancer Reporting (ICCR)
    Guidelines

    Bossuyt, V.; Provenzano, E.; Symmans, W. F.; Webster, F.; Allison, K. H.; Dang, C.; Gobbi, H.; Kulka, J.; Lakhani, S. R.; Moriya, T.; more...
    Histopathology (2024)

    Fulltext@MSK | Save
  • Patient metabolic profile defined by liver and muscle (18)F-FDG PET avidity is independently associated with overall survival in gastric cancer
    Journal Article

    Vitiello, G. A.; Jayaprakasam, V. S.; Tang, L. H.; Schattner, M. A.; Janjigian, Y. Y.; Ku, G. Y.; Maron, S. B.; Schoder, H.; Larson, S. M.; Gönen, M.; more...
    Gastric Cancer (2024)

    Fulltext@MSK | Save
  • Clinical practice guidelines for esophagogastric junction cancer: Upper GI Oncology Summit 2023
    Guidelines

    Kitagawa, Y.; Matsuda, S.; Gotoda, T.; Kato, K.; Wijnhoven, B.; Lordick, F.; Bhandari, P.; Kawakubo, H.; Kodera, Y.; Terashima, M.; more...
    Gastric Cancer (2024)

    Fulltext@MSK | Save
  • Impact of rabbit anti-thymocyte globulin (ATG) exposure on outcomes after ex vivo T-cell–depleted hematopoietic cell transplantation in pediatric and young adult patients
    Journal Article

    Lakkaraja, M.; Mauguen, A.; Boulad, F.; Cancio, M. I.; Curran, K. J.; Harris, A. C.; Kernan, N. A.; Klein, E.; Kung, A. L.; Oved, J.; more...
    Cytotherapy (2024)

    Fulltext@MSK | Save
  • A comparison of 3-year follow-up of ZUMA-5 (axicabtagene ciloleucel) with SCHOLAR-5 in relapsed/refractory follicular lymphoma
    Editorial

    Ghione, P.; Palomba, M. L.; Ray, M. D.; Limbrick-Oldfield, E. H.; Owen, J.; Kanters, S.; Bobillo, S.; Ribiero, M. T.; Jacobson, C. A.; Neelapu, S. S.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Prolonged gastrointestinal manifestations after recovery from COVID-19
    Journal Article

    Elmunzer, B. J.; Palsson, O. S.; Forbes, N.; Zakaria, A.; Davis, C.; Canakis, A.; Qayed, E.; Bick, B.; Pawa, S.; Tierney, W. M.; more...
    Clinical Gastroenterology and Hepatology (2024)

    Fulltext@MSK | Save
  • Racial disparities in mycosis fungoides/Sézary syndrome–A single-center observational study of 292 patients
    Journal Article

    Gandham, A. R.; Geller, S.; Dusza, S. W.; Kupper, T. S.; Myskowski, P. L.
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Long-term experience with tepotinib in Japanese patients with MET exon 14 skipping NSCLC from the phase II VISION study
    Journal Article

    Morise, M.; Kato, T.; Matsumoto, S.; Inoue, T.; Sakamoto, T.; Tokito, T.; Atagi, S.; Kozuki, T.; Takeoka, H.; Chikamori, K.; more...
    Cancer Science (2024)

    Fulltext@MSK | Save
  • Postradical prostatectomy prostate-specific antigen outcomes after 6 versus 18 months of perioperative androgen-deprivation therapy in men with localized, unfavorable intermediate-risk or high-risk prostate cancer: Results of part 2 of a randomized phase 2 trial
    Journal Article

    McKay, R. R.; Xie, W.; Yang, X.; Acosta, A.; Rathkopf, D.; Laudone, V. P.; Bubley, G. J.; Einstein, D. J.; Chang, P.; Wagner, A. A.; more...
    Cancer (2024)

    Fulltext@MSK | Save
  • Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy
    Guidelines

    Crombie, J. L.; Graff, T.; Falchi, L.; Karimi, Y. H.; Bannerji, R.; Nastoupil, L.; Thieblemont, C.; Ursu, R.; Bartlett, N.; Nachar, V.; more...
    Blood (2024)

    Fulltext@MSK | Save